Public Company News

Visionary Holdings' Changle Shuang Carries Out Biotechnology Health Public Welfare Activities for Society

TORONTO, May 27, 2025 /PRNewswire/ -- On May 23, 2025, Changle Shuang, a subsidiary of Visionary Holdings (Nasdaq: GV), officially reached a strategic partnership with the Guangzhou Jianjia Charity Foundation inGuangzhou. The two parties signed a strategic cooperation agreement around the "Health...

2025-05-27 21:00 3353

Taoping Announces 1-for-30 Reverse Stock Split

SHENZHEN, China, May 27, 2025 /PRNewswire/ -- Taoping Inc. (Nasdaq: TAOP, the "Company"), a provider of innovative smart cloud platform services and solutions, today announced that the board of directors of the Company approved a one-for-thirty reverse stock split of the Company's issued and outs...

2025-05-27 20:30 3559

GIBO Announces Successful Application of inspirAI in Short Drama, Completes Thematic Creation Tests with HoneyReels, Pioneering Cross-Format Innovation in Anime and Live-Action Short Drama

HONG KONG, May 27, 2025 /PRNewswire/ -- GIBO Holdings Ltd. (NASDAQ: GIBO), Asia's leading AI-generated content platform, today announced the successful application of its proprietaryinspirAI™ technology in short drama creation, marking a major advancement in GIBO's cross-format storytelling capab...

2025-05-27 20:30 2327

U Power Limited Receives "Beyond Impact Award" at the 5th BEYOND International Technology Innovation Expo in Macau

Beyond Impact Award recognizes companies with substantial contributions to the environment, society, economy, and technology, aligning with the UN's Sustainable Development Goals SHANGHAI, May 27, 2025 /PRNewswire/ -- U Power Limited (Nasdaq: UCAR) (the "Company" or "U Power"), a provider of com...

2025-05-27 20:30 2138

Cheche Group to Participate in Maxim Group's 2025 Virtual Tech Investor Conference: Discover the Innovations Reshaping Tomorrow

BEIJING, May 27, 2025 /PRNewswire/ -- Cheche Group Inc. (NASDAQ: CCG) ("Cheche" or the "Company"), China's leading auto insurance technology platform, today announced that the Company will be participating in an upcoming investor conference. Maxim Group's 2025 V...

2025-05-27 20:30 3403

Trip.com Group Announces Repurchase Right Notification for 1.50% Exchangeable Senior Notes due 2027

SINGAPORE, May 27, 2025 /PRNewswire/ -- Trip.com Group Limited (Nasdaq: TCOM; HKEX: 9961) ("Trip.com Group" or the "Company"), a leading one-stop travel service provider of accommodation reservation, transportation ticketing, packaged tours, and corporate travel management, today announced that i...

2025-05-27 18:00 3768

Qifu Technology Won the Title of "MOST HONORED COMPANY" for the Second Consecutive Year

SHANGHAI, May 27, 2025 /PRNewswire/ -- Recently, Qifu Technology (Nasdaq: QFIN; Hong Kong Stock Exchange: 3660), a leading Chinese fintech company, has secured the title of "Most Honored Company" in the 2025 Extel Asia (ex-Japan) Best Managed Teams rankings, a global leader in corporate governanc...

2025-05-27 14:19 3346

Tuniu to Report First Quarter 2025 Financial Results on June 12, 2025

NANJING, China, May 27, 2025 /PRNewswire/ -- Tuniu Corporation (NASDAQ:TOUR) ("Tuniu" or the "Company"), a leading online leisure travel company inChina, today announced that it plans to release its unaudited financial results for the first quarter endedMarch 31, 2025, before the market opens on ...

2025-05-27 14:00 3338

ZYLOX Unicorn™ Vascular Closure Device Receives Regulatory Approval in Indonesia

HANGZHOU, China, May 26, 2025 /PRNewswire/ -- Zylox-Tonbridge Medical Technology Co., Ltd. ("Zylox-Tonbridge" or the "Company") today announced that its proprietary ZYLOX Unicorn™ Vascular Closure Device (VCD) has received regulatory approval inIndonesia. This marks the ZYLOX Unicorn™ Vascular Cl...

2025-05-27 10:14 2067

Pony.ai Partners with Dubai RTA to Accelerate Autonomous Mobility in the Middle Eastern Metropolis

DUBAI, UAE, May 26, 2025 /PRNewswire/ -- Pony.ai (NASDAQ: PONY) today announces that it has entered a Memorandum of Understanding (MoU) with Dubai's Roads and Transport Authority (RTA) to deploy its advanced robotaxi fleet in the region. The collaboration underscores Pony.ai's commitment to advan...

2025-05-27 10:00 2217

Pro Anime AI Video Generation Platform Animon.ai Launches in Korea

Key technology upgrades accompany market entry, providing an even better user experience TOKYO and SEOUL, South Korea, May 26, 2025 /PRNewswire/ -- CreateAI Holdings ("CreateAI" or the "Company") today announced market entry in Korea and significant updates to its groundbreaking AI anime video g...

2025-05-27 09:00 3934

RBW Signs Strategic Partnership with NetEase Cloud Music to Expand K-POP's Global Reach Among Chinese Youth

HANGZHOU, China, May 26, 2025 /PRNewswire/ -- RBW Inc. (KOSDAQ: 361570), a leading integrated content production company and home to top K-POP acts such as MAMAMOO, ONEUS, ONEWE, and PURPLE KISS, has entered into a strategic copyright partnership with NetEase Cloud Music (HKEX: 9899), one ofChina...

2025-05-26 22:00 2818

Lunit Highlights AI's Role in Advancing Precision Oncology at ASCO 2025 with 12 Studies

SEOUL, South Korea, May 26, 2025 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI for cancer diagnostics and therapeutics, today announced that 12 studies featuring its AI-powered digital pathology solution will be presented at the 2025 American Society of Clinical Oncology (ASCO) ...

2025-05-26 21:00 2212

Dizal to Highlight its Portfolio Advances in Hematologic Malignancies and Lung Cancer at ASCO 2025

* DZD8586 demonstrated significant anti-tumor efficacy in heavily pretreated chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) patients with ORR of 84.2% * DZD6008, a BBB-penetrant 4th generation EGFR TKI, showed encouraging and durable anti-tumor activity with favorable safet...

2025-05-26 18:06 2181

Celltrion's YUFLYMA® (adalimumab-aaty) receives FDA interchangeability designation for all its approved dosage forms and strengths

* YUFLYMA® (adalimumab-aaty) is a high-concentration (100mg/mL) and citrate-free formulation of Humira® (adalimumab) biosimilar[1] * Celltrion previously received interchangeability (IC) designation for YUFLYMA® (adalimumab-aaty) in prefilled syringes (20mg & 80mg); Expanded interchangeabilit...

2025-05-24 01:47 4327

/DISREGARD RELEASE: Celltrion/

We are advised by Celltrion that journalists and other readers should disregard the news release, Celltrion's YUFLYMA® (adalimumab-aaty) receives FDA interchangeability designation for all its approved dosage forms and strengths, issued21-May-2025 over PR Newswire. ...

2025-05-24 00:01 4239

Mabwell Announces Clinical Data of Multiple ADCs to be presented at 2025 ASCO Annual Meeting

SHANGHAI, May 23, 2025 /PRNewswire/ -- Mabwell (688062.SH), an innovation-driven biopharmaceutical company with entire industry chain, announced multiple clinical research results to be presented at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting, including phase Ib/II clini...

2025-05-23 22:00 4310

WGC2025 | ENN Leverages "Intelligence + Low Carbon" to Pioneer a New Paradigm for Sustainable Energy Development

LANGFANG, China, May 23, 2025 /PRNewswire/ -- From May 19 to 23, 2025, the 29th World Gas Conference (WGC2025), hosted by the International Gas Union (IGU), convened inBeijing. As the premier global event in the energy sector, WGC2025 attracted leading companies and industry experts from around t...

2025-05-23 20:00 3959

Eason Technology Limited Receives Notification from NYSE Regarding Delayed Form 20-F Filing

HONG KONG, May 23, 2025 /PRNewswire/ -- Eason Technology Limited ("Eason Technology" or the "Company") (NYSE:DXF

2025-05-23 18:30 4941

Tuniu Announces Receipt of Minimum Bid Price Notice from Nasdaq

NANJING, China, May 23, 2025 /PRNewswire/ -- Tuniu Corporation (Nasdaq: TOUR) ("Tuniu" or the "Company"), a leading online leisure travel company inChina, today announced that it has received written notification from the staff of the Listing Qualifications Department of the Nasdaq Stock Market L...

2025-05-23 17:00 4354
1 ... 83848586878889 ... 779

Week's Top Stories